Active Not RecruitingNCT03932136
Sulforaphane and risk of psychosis in people at clinical high risk
About this title
Read the official source — NCT03932136Placebo comparisonAges 15–45ChinaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 15 years to 45 years.
- Listed locations
- Guangzhou and 8 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 14, 2019
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 300
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Combination product, Dietary supplement
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- China
- Age range
- From 15 Years to 45 Years
- Official registry ID
- NCT03932136
- Official title
Show the full official title
Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial)
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Guangzhou · Zhengzhou · Changsha
4 more locations
- Suzhou
- Shanghai
- Shenzhen
- Tianjin
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Jiao Tong University School of Medicine, a university.
Who can participate?
Listed age limits: 15 years to 45 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
